Category Specific RSS

joshua fegan

Althea’s cost-cutting proves effective, enters positive cash flow in Q1 FY24

After witnessing a cash burn of $368k in the previous quarter, Cannabis-based pharmaceutical company Althea Group (ASX: AGH) has entered…

2 years ago

Althea Group delivering record year following expansion into global markets

The cheers of the cannabis industry can be heard loud and clear as the demand for the plant continues to…

3 years ago

Free weed for the leprechauns as Althea Group enters Ireland

The burgeoning arms of cannabis treatment have made their way to Ireland, with regulators easing restrictions which has increased the…

3 years ago

Althea to launch low-cost cannabis as medicinal gateway option

If Australians have reservations about the use of medicinal cannabis to cure their ailments, there will soon be a low-cost…

4 years ago

Althea lands first purchase order with WeedMD for cannabis products

Medicinal cannabis and research company Althea Group (ASX: AGH) has today announced that its Canadian subsidiary, Peak Processing, has received…

4 years ago